The anticonvulsant gabapentin decreases firing rates of substantia nigra pars reticulata neurons

European Journal of Pharmacology

Volumn 316, Issue 2-3, 1996, Pages 211-218

  Bloms Funke, Petra ^a   Löscher, Wolfgang ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Anti epileptic drugs; Epilepsy; GABA ( aminobutyric acid); Midbrain

Indexed keywords

FENTANYL; GABAPENTIN; GALLAMINE; METHOHEXITAL; MUSCLE RELAXANT AGENT;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANTICONVULSANT ACTIVITY; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; FEMALE; GABAERGIC SYSTEM; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; SINGLE UNIT ACTIVITY; SUBSTANTIA NIGRA;

ACETIC ACIDS; AMINES; ANIMALS; ANTICONVULSANTS; CYCLOHEXANECARBOXYLIC ACIDS; EPILEPSY; FEMALE; GAMMA-AMINOBUTYRIC ACID; RATS; RATS, WISTAR; SUBSTANTIA NIGRA;

EID: 0030571498     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00682-6     Document Type: Article

References (32)

1. Adams, J.C., 1981, Heavy metal intensification of DAB-based HRP reaction product, J. Histochem. Cytochem. 29, 775.
2. Bartoszyk, G.D., N. Meyerson, W. Reimann, G. Satzinger and A. von Hodenberg, 1986, Gabapentin, in: New Anticonvulsant Drugs, eds. B.S. Meldrum and R.J. Porter (John Libbey, London) p. 147.
3. Bonhaus, D.W., R.D. Russell and J.O. McNamara, 1991, Activation of substantia nigra pars reticulata neurons: Role in the initiation and behavioral expression of kindled seizures, Brain Res. 545, 41.
4. Bonhaus, D.W., J.R. Walters and J.O. McNamara, 1986, Activation of substantia nigra neurons: Role in the propagation of seizures in kindled rats, J. Neurosci. 6, 3024.
5. Bunney, B.S., J.R. Walters, R.H. Roth and G.K. Aghajanian, 1973, Dopaminergic neurons: Effect of antipsychotic drugs and amphetamine on single cell activity, J. Pharmacol. Exp. Ther. 185. 560.
6. Chadwick, D. 1995, Gabapentin. Clinical use, in: Anti-epileptic Drugs, Vol. 4, eds. R.H. Levy. R.H. Mattson and B.S. Meldrum (Raven Press, New York, NY) p. 851.
7. Faillon, J.H. and S.E. Loughlin, 1995, Substantia nigra, in: The Rat Nervous System, Vol. 2, ed. G. Paxinos (Academic Press, New York, NY)p. 215.
8. Fichter, N., C.P. Taylor and T.J. Feuerstein, 1996, Nipecotate-induced GABA release from slices of the rat caudato-putamen: Effects of gabapentin, Naunyn-Schmiedeberg's Arch. Pharmacol., in press.
9. Gale, K. 1988, Progression and generalization of seizure discharge: Anatomical and neurochemical substrates, Epilepsia 29 (Suppl. 2), S15.
10. Gale, K. 1992, GABA and epilepsy: Basic concepts from preclinical research, Epilepsia 33 (Suppl. 5), S3.
11. Götz, E., T.J. Feuerstein and D.K. Meyer, 1993, Effects of gabapentin on release of gamma-aminobutyric acid from slices of rat neostriatum, Arzneim.-Forsch. (Drug Res.) 43, 636.
12. Guyenet, P.G. and G.K. Aghajanian, 1978, Antidromic identification of dopaminergic and other output neurons of the rat substantia nigra, Brain Res. 150, 69.
13. Honmou, O., J.D. Kocsis and G.B. Richerson, 1995a, Gabapentin potentiates the conductance increase induced by nipecotic acid in CA1 pyramidal neurons in vitro, Epilepsy Res. 20, 193.
14. Honmou, O., A.A. Oyelese and J.D. Kocsis, 1995b, The anticonvulsant gabapentin enhances promoted release of GABA in hippocampus: A field potential analysis, Brain Res. 692, 273.
15. Kocsis, J.D. and O. Honmou, 1994, Gabapentin increases GABA-induced depolarization in rat neonatal optic nerve, Neurosci. Lett. 169, 181.
16. Löscher, W. 1989, Valproate enhances GABA turnover in the substantia nigra, Brain Res. 501, 198.
17. Löscher, W. 1993, Effects of the anti-epileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain, Neurochem. Res. 18, 485.
18. Löscher, W. and U. Ebert, 1996, Basic mechanisms of seizure propagation: Targets for rational drug design and rational polypharmacy, Epilepsy Res. (Suppl.), in press.
19. Löscher, W, and D. Schmidt, 1994, Strategies in anti-epileptic drug development: Is rational drug design superior to random screening and structural variation? Epilepsy Res. 17, 95.
20. Löscher, W. and W.S. Schwark, 1985, Evidence for impaired GABAergic activity in the substantia nigra of amygdaloid kindled rats, Brain Res. 339, 146.
21. Löscher, W., D. Hönack and C.P. Taylor, 1991, Gabapentin increases aminooxyacetic acid-induced GABA accumulation in several regions of rat brain, Neurosci. Lett. 128, 150.
22. Löscher, W., A. Rohlfs and C. Rundfeldt, 1995, Reduction in firing rate of substantia nigra pars reticulata neurons by valproate: Influence of different types of anesthesia in rats, Brain Res. 702, 133.
23. Olsen, R.W., J.K. Wamsley, R.J. Lee and P. Lomax, 1986, Benzodiazepine/barbiturate/GABA receptor - chloride ionophore complex in a genetic model for generalized epilepsy, in: Basic Mechanisms of the Epilepsies. Molecular and Cellular Approaches, eds. A,V. Delgado-Escueta, A.A.J. Ward. D.M. Woodbury and R.J. Porter (Raven Press, New York, NY) p. 365.
24. Paxinos, G. and C. Watson, 1986, The Rat Brain in Stereotaxic Coordinates (Academic Press, Sydney).
25. Petroff, O.A.C., D.L. Rothman, K.L. Behar, D. Lamoureux and R.H. Mattson, 1996, The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy, Ann. Neurol. 39, 95.
26. Rohlfs, A., C. Rundfeldt R. Koch and W. Löscher, 1996, A comparison of the effects of valproate and its major active metabolite E-2-envalproate on single unit activity of substantia nigra pars reticulata neurons in rats, J. Pharmacol. Exp. Ther. 277, 1305.
27. Simons, D.J. and P.W.A. Land, 1987, A reliable technique for marking the location of extracellular recording sites using glass micropipettes, Neurosci. Lett. 81, 100.
28. Taylor, C.P., M.G. Vartanian, R. Andruszkiewiewicz and R.B. Silverman, 1992, 3-Alkyl GABA and 3-alkylglutamic acid analogues: Two new classes of anticonvulsant agents, Epilepsy Res. 11, 103.
29. Taylor, C.P. 1995, Gabapentin. Mechanisms of action, in: Anti-Eipileptic Drugs, Vol. 4, eds. R.H. Levy, R.H. Mattson and B.S. Meldrum (Raven Press, New York, NY) p, 829.
30. Vollmer, K.O., A. von Hodenberg and E.U. Kolle, 1986, Pharmacokinetics and metabolism of gabapentin in rat, dog and man, Arzneim. -Forsch. (Drug Res.) 36, 830.
31. Waszczak, B.L., E.K. Lee and J.R. Walters, 1986, Effects of anticonvulsant drugs on substantia nigra pars reticulata neurons, J. Pharmacol. Exp. Ther. 239, 606.
32. Welty, D.F., G.P. Schielke, M.G. Vartanian and C.P. Taylor, 1993, Gabapentin anticonvulsant action in rats: Disequilibrium with peak drug concentrations in plasma and brain microdialysate, Epilepsy Res. 16, 175.